Dermaphex

Aphex BioCleanse System’s (SNST) Significant Hand Sanitizer Purchase Order.

Aphex BioCleanse Systems Announces Significant Purchase Order for Proprietary, Alcohol-Free Hand Sanitizer Product PITTSFORD, N.Y. , May 4, 2021 /PRNewswire/ -- Aphex...

13 Keys to a Successful FDA Advisory Committee Meeting (Regulatory Focus)

RAPS' Latest | 01 August 2019 | By Zachary Brousseau  When the US Food and Drug Administration (FDA) has significant...
video

Video: What to Look for in Public Company Management.

In this episode MicroCapClub interviews author and fund manager Michael Shearn. Michael discusses management teams that focus on solving...
GBT Technologies

GBT (GTCH) Is Researching To Develop An AI Empowered, Wireless Patient Health Monitoring System

The researched technology, is aiming to create a Radio-Based patient health monitoring system for homes or facilities SAN...

Bill Gates Warns That a Next Pandemic Could Be 10 Times Worse.

Well Alrighty Then. Just as we Were Starting to Get Comfortable Sitting on a Barstool Again.. The Microsoft co-founder...

Silo Pharma (SILO) Issues Letter to Shareholders

Silo Pharma Issues Letter to Shareholders Detailing Progress on Pipeline Assets Combining Traditional Therapeutics with Psychedelic Medicine LIVE...

Adding Brainstorm Therapeutics (BCLI) $4.59 to CoronaVirus Watchlist.

This is a company exploring the use of stem cells for a number of ailments. The lead program is (or was) for...
Revive Therapeutics

Revive Therapeutics Gains 25% on Positive FDA Comments.

The Company stated yesterday that it "has received positive comments from the FDA in regard to the Company’s request to determine and...
OMNIQ

OMNIQ (OMQS) $5.00 Reports $15.8 Million 3Q, up 21%.

OMNIQ Corp. Reports Strong Sales of $15.8 Million for Third Quarter of 2020, up 21% Year over Year

Latest article

Institutional Analyst Newsletter. Citius (CTXR), GeoVax (GOVX.

DERBY WEEKEND - WE'RE HEADED TO TAMPA!HAT'S ON, DRINK'S UPADDING CITIUS PHARMA (CTXR) $0.66, TO WATCHLISTUPDATING GEOVAX LABS (GOVX) $1.43OUR $26...

Adding Citius Pharma (CTXR) $0.66 to 2024 Watch List.

Three Years Since we Last Added Citius (CTXR) to the Watch List, and it Looks Better Than Ever!

Citius Pharmaceuticals (CTXR) Prospectus, Powerpoint & Fact Sheet.

CRANFORD, N.J., April 26, 2024 /PRNewswire/ -- Citius Pharmaceuticals Inc. (Nasdaq: CTXR) ("Citius" or the "Company"), a late-stage biopharmaceutical company dedicated to the development and commercialization...